公开(公告)号：US20190160114A1

公开(公告)日：2019-05-30

申请号：US16320702

申请日：2017-07-28

申请人： ISOThrive LLC

发明人： Lee Madsen, II ,  Jack Oswald ,  Sarah Stanley

IPC分类号： A61K35/66 ,  C12Q1/68 ,  C12Q1/04 ,  A61K31/702 ,  A61K31/732 ,  A61K31/733

摘要： Methods are described herein for identifying and providing prebiotic compositions that are optimized for the health needs of individuals.

公开(公告)号：US20190093139A1

公开(公告)日：2019-03-28

申请号：US16092362

申请日：2017-04-11

申请人： ISOThrive LLC

发明人： Lee Madsen, II ,  Jack Oswald ,  Sarah Stanley

IPC分类号： C12P19/18 ,  C12P19/04

摘要： Described herein are efficient, low cost methods for making prebiotics that contain maltosyl-isomaltooligosaccharides (MIMOs), as well as compositions made by such methods.

公开(公告)号：US20240041944A1

公开(公告)日：2024-02-08

申请号：US18181504

申请日：2023-03-09

申请人： ISOThrive LLC

发明人： Lee Madsen, II ,  Jack Oswald ,  Sarah Stanley

IPC分类号： A61K35/66 ,  A61K31/702 ,  A61K31/732 ,  A61K31/733 ,  A61P1/00 ,  A61P3/00 ,  A61P35/00 ,  A61P5/00 ,  C12Q1/689 ,  A61K35/744 ,  A61K31/717 ,  A61K31/715 ,  A61K31/718 ,  A61K31/736 ,  C12Q1/04 ,  C12Q1/68

CPC分类号： A61K35/66 ,  A61K31/702 ,  A61K31/732 ,  A61K31/733 ,  A61P1/00 ,  A61P3/00 ,  A61P35/00 ,  A61P5/00 ,  C12Q1/689 ,  A61K35/744 ,  A61K31/717 ,  A61K31/715 ,  A61K31/718 ,  A61K31/736 ,  C12Q1/04 ,  C12Q1/68

摘要： Methods are described herein for identifying and providing prebiotic compositions that are optimized for the health needs of individuals.

公开(公告)号：US20200055905A1

公开(公告)日：2020-02-20

申请号：US16347407

申请日：2017-11-07

申请人： ISOThrive LLC

发明人： Lee Madsen II ,  Jack Oswald ,  Sarah Stanley ,  Yvonne Lorraine Kapila

IPC分类号： C07K14/315 ,  A61K35/741 ,  A61P35/00

摘要： Methods are described herein for generating beneficial compounds and/or materials such as bacteriocins that include contacting ‘challenger’ microbes with the ‘protagonist’ microorganisms. The challenger microbes do not directly manufacture the beneficial compounds and/or materials and instead stimulate the protagonist microorganisms to produce beneficial compounds and materials. The protagonist and/or challenger microorganisms can be administered to a subject so the beneficial compounds and/or materials can be made in vivo. Compositions and methods of using beneficial compounds and/or materials are also described herein.